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Background. Presently, we do not have a clear picture of
how the mesangial transcriptome evolves following stimulation.
The present study was designed to address this, using an innate
trigger to stimulate murine mesangial cells.
Methods. Three independent mesangial cell lines derived
from C57BL/6 mice were stimulated with lipopolysaccharide
(LPS). The mesangial cell transcriptomes were defined 1, 6, 24,
and 60 hours poststimulation with LPS, using a 17,000 gene
oligonucleotide array.
Results. Interferon regulatory factor-1 (IRF-1), ScyA2/
MCP1, ScyA20/MIP3a (ScyB1/Gro1, and ScyB2/MIP2a/Gro2
were the earliest genes to be hyperexpressed after LPS stim-
ulation. Later-appearing genes included ScyA7/MCP3, ScyD1/
fractalkine, GM-CSF/CSF-2, PDGF, epiregulin, NfKb, C/EBP,
TIMP-1, MMP11, MMP13, PTGS2/COX2, SpI2-1, Spp1, PAI-
1, VCAM-1, C3, and defensin-b1, among others. Several of these
changes were validated by real-time polymerase chain reac-
tion (PCR) or enzyme-linked immunosorbent assay (ELISA).
Rapid IRF-1 hyperexpression was also noted following stim-
ulation of mesangial cells with peptidoglycan, poly I:poly C,
interferon-c ?(IFN-c), and heat-aggregated IgG. However, the
blocking of IRF-1 using RNA interference and the use of mesan-
gial cells isolated from IRF-1–deficient mice could not substan-
tiate an obligatory role for IRF-1 in LPS-induced mesangial
cell activation. Likewise, IRF-1 deficiency did not impact the
development of anti-glomerular basement membrane (GBM)-
induced immune nephritis.
Conclusion. Innate stimuli such as LPS appear to trigger
successive waves of mesangial cell gene expression. Although
IRF-1 surfaces as an “early-on, early-off” transcription factor
following several different triggers, it does not appear to be an
essential molecule for mesangial cell activation by innate trig-
gers or for anti-GBM disease.
The mesangial cell constitutes a key glomerular cell
type that plays a potentially important role in the patho-
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genesis of several renal diseases [1–3]. In particular, it
has been recognized to produce a rich array of me-
diators, including cytokines and chemokines, reactive
oxygen species, nitric oxide, prostaglandins, etc. In ad-
dition, these cells possess unique contractile properties
that allow them to regulate the local blood flow in the
glomerulus. Finally, they also elaborate the glomerular
basement membrane (GBM) matrix and contribute to
the fibrosclerotic lesions seen later in disease, following
a variety of primary triggers.
Although a rich literature exists detailing the up-
regulation of several different molecules in mesangial
cells upon stimulation, little information is currently
available concerning the transcriptome of stimulated
mesangial cells. This is an important impetus for the cur-
rent study. In addition, ongoing research in our labora-
tory implicates genetically encoded differences in the end
organs as being potentially important in facilitating the
development of immune nephritis [4, 5]. Clearly, it is im-
perative to define the “normal” mesangial transcriptome
in detail before any potential strain or locus specific ge-
netic aberrations can be examined in the future. This is a
second factor that has inspired the present study.
A wide variety of stimuli have been documented to
trigger mesangial cells, including innate stimuli triggering
different Toll receptors, interferon-c (IFN-c), interleukin
(IL)-1, and other cytokines, and immune complexes [1–
3]. This manuscript focuses on mesangial transcriptomic
changes following stimulation of Toll-like receptor 4
(TLR4), using lipopolysaccharide (LPS). As a follow-up,
this study also tests the functional importance of one of
the earliest transcription factors up-regulated following
mesangial cell stimulation, interferon regulatory factor-1
(IRF-1).
METHODS
Mesangial cell isolation and stimulation
Three independent mesangial cell lines (labeled B6-
M3, B6-M4, and B6-M14) were derived from three
2-month-old C57BL/6 (B6)3 mice following previously
documented protocols [6]. Likewise, mesangial cells were
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also prepared from B6.IRF-1−/− mice, purchased from
Jackson Laboratories (Bar Harbor, ME, USA). Essen-
tially, renal cortices from the kidneys were minced and
then pressed through a series of sieves of decreasing pore
size (250 lm mesh, 150 lm, and 75 lm). The glomeruli
were collected on the finest sieve (>95% purity, as as-
sessed microscopically), washed with sterile phosphate-
buffered saline (PBS), and cultured in Dulbecco’s mod-
ified Eagle’s medium (DMEM) supplemented with
nonessential amino acids, 2-mercaptoethanol (2-ME),
antibiotics, and 10% horse serum. Importantly, this
medium contained D-valine, instead of L-valine, to sup-
press fibroblast outgrowth. Although these cultures ini-
tially possessed other glomerulocyte cell types, notably
podocytes, mesangial cells outgrew other cell types after 2
weeks of culture. Flow cytometric analyses of the cultured
cells revealed them to be large (based on forward scat-
ter), complex (as ascertained by side scatter) and myosin
positive, but negative for keratin, von Willebrand factor,
and CD45. All mesangial cells were used between the
10th and 20th passage of cultivation. Cells were plated in
serum-free medium and stimulated with LPS at 10 ng/mL.
At the indicated time points (0, 1, 6, 24, and 60 hours
after LPS stimulation), aliquots of cells were processed
for RNA isolation. In other experiments, mesangial cells
were stimulated with peptidoglycan (100 ug/mL), poly
I:C (100 ug/mL), cytosine phosphate guanosine (CpG)
oligonucleotides (10 nmol/L), IL-1b (1 ng/mL), INF-c
(5 ng/mL), or total rabbit IgG (10 ug/mL), purchased
from Sigma Chemical Co. (St. Louis, MO, USA). These
concentrations were selected based on preliminary dose-
response experiments with each individual trigger.
Microarray studies
All protocols used for the microarray studies are de-
tailed at the following Web site: http://microarraycore.
swmed.edu/tech support.html. Total RNA was prepared
using RNAeasy Mini Kit (Qiagen, Valencia, CA,
USA), using manufacturer-suggested protocols. Iso-
lated RNA was amplified once using MessageAmp
aRNA kit (Ambion, Woodward, TX, USA), follow-
ing manufacturer-suggested protocols. We have pre-
viously established the relative utility and reliability
of using amplified RNA (aRNA) versus unamplified
RNA (http://microarraycore.swmed.edu/). The aRNA
prepared was then labeled with cyanine-3 (Cy3) or
cyanine-5 (Cy5), using the ASAP aRNA Labeling Kit
(Perkin-Elmer, Wellesley, MA, USA). Both sets of la-
beled probes were mixed and hybridized to a mouse
17K-oligonucleotide array, consisting of oligonucleotides
drawn from the Unigene cluster. The gene content of
this array is detailed at the University of Texas South-
western Medical Center Microarray Core’s Web site
(http://microarraycore.swmed.edu/). Following a series of
washes with standard sodium citrate (SSC) and sodium
dodecyl sulfate (SDS)-containing buffers, the slides were
spin-dried, and scanned using Genepix 4000B. Recorded
pixel intensities in the Cy3 and Cy5 fluorescent channels
were digitally stored, and analyzed as described below.
Microarray data analysis
The chips were first examined for hybridization qual-
ity; isolated subgrids where the hybridization was not
satisfactory were flagged and genes from those regions
were excluded from further analysis. Although there were
17,000 gene spots on the arrays, about 44% of the spots
were flagged away for being unsatisfactory, so that each
array yielded only about 9500 data points, on the aver-
age. Among the genes that displayed differential expres-
sion, the chip-to-chip consistency was good, with the in-
terchip correlation coefficients ranging from 0.35 to 0.78.
Fluorescence intensities on all arrays were next subgrid
normalized. To remove noise, the mean pixel intensity of
each gene was then compared to the local background in-
tensity. Genes that exhibited intensities that were <2 SD
above the mean background intensity in >75% of com-
ponent pixels were excluded from analysis. In addition,
genes whose mean fluorescence intensities fell below 1%
of the array-wide maximal fluorescence intensity were
also excluded.
Of the remaining array spots, those that differed in
expression between the control (i.e., unstimulated) and
experimental (i.e., LPS-stimulated) by > twofold were
examined further. Hierarchic clustering was performed
using Gene Traffic (Iobion, La Jolla, CA, USA), based the
Pearson correlation distance metric and the “average”
clustering algorithm. Statistical significance of any ob-
served expression differences between the unstimulated
and stimulated samples were determined using the Stu-
dent t test (Sigmastat) (Jandel Scientific, San Rafael, CA,
USA). Since the expression differences failed to main-
tain significance after multiple testing correction (be-
cause of the small number of arrays studied, and the large
number of genes being analyzed), the validity of the ob-
served expression differences were confirmed by one of
two orthogonal methods, real-time reverse transcription-
polymerase chain reaction (RT-PCR) or enzyme-linked
immunosorbent assay (ELISA) measurement of corre-
sponding protein levels, for selected genes showing max-
imal expression differences at the different time points
studied. All microarray data detailed in this communica-
tion are freely available from the corresponding author.
Potential transcription factor binding sites were identi-
fied as follows. The sequence of each differentially ex-
pressed gene was accessed on the Ensembl database
(www.ensembl.org). One thousand base pairs upstream
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Table 1. Primer sequences used for real-time reverse
transcription-polymerase chain reaction (RT-PCR) studies
Mouse Gene Primer sequence
GAPDH 5′ AACGACCCCTTCATTGAC
3′ TCCACGACATACTCAGCAC
IRF-1 5′ CATTCACACAGGCCGATACAAAGC
3′ CAACGGAAGTTTGCCTTCCATGTC
GRO1 5′ CCTGAAGCTCCCTTDDTTCAGAAA
3′ GCCATCAGAGCAGTCTGTCTTCTT
C3 5′ CAGAGCTGGTTGTGGACCATAGAA
3′ AATCTCCCAGGTGGTGATGGAATC
MMP-13 5′ CTGGTCTGATGTGACACCACTGAA
3′ CCAGAAGACCAGAAGGTCCATCAA
Abbreviations are: GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
IRF-1, interferon regulatory factor-1; GRO1, growth-regulated oncogene 1; C3,
complement C3; MMP-13, matrix metalloproteinase-13.
of each gene were selected and tested for transcrip-
tion factor binding sites using the TESS database (http://
www.cbil.upenn.edu/tess/). The stringency of comparison
was set so that only putative binding sites with >90%
match over eight consecutive base pairs, and an La/length
ratio of 2.0 were considered (where La represents the log
likelihood score). The respective percentages of all hyper-
expressed genes that exhibited the different transcription
factor binding sites were then computed.
Real-time RT-PCR studies
Total RNA was isolated from the mesangial cells
as described above and quantitated spectrophotometri-
cally. RT-PCR was performed using the enhanced avian
horse serum (HS) RT-PCR kit (Sigma Chemical Co.), ac-
cording to the manufacturer’s protocol. Real-time PCR
was performed using GeneAmp 5600 (Perkin-Elmer),
using primers whose sequences are listed in Table 1.
For each pair of primers, PCR was performed over
a range of cycles, and the relationship between the
quantity of RNA substrate and the final PCR prod-
uct was defined. Glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) was assayed in parallel, as an inter-
nal control. For both the test message and the GAPDH
control, the CT was determined, where CT refers to
the number of PCR cycles required to reach a product
intensity threshold. The CT of each test message was
first normalized using the CT for GAPDH, assayed in
the same sample. Fold change was next calculated us-
ing the relative CT method, as follows: fold change =
2 (normalized CT in resting sample − normalized CT in stimulated sample).
ELISA
Granulocyte macrophage-colony-stimulating factor
(GM-CSF), monocyte chemoattractant protein-1 (MCP-
1), matrix metalloproteinase-13 (MMP-13), and tissue
inhibitors of metalloproteinase-1 (TIMP-1) protein lev-
els were measured using commercially available ELISA
kits (R&D Systems, Minneapolis, MN, USA), follow-
ing manufacturer-suggested protocols. Briefly, Immulon
I ELISA plates were first coated with the respective
capture antibodies specific for the different chemokines
or cytokines. The plates were then blocked overnight
with PBS supplemented with 3% bovine serum albumin
(BSA), 0.1% gelatin, and 3 mmol/L ethylenediaminete-
traacetic acid (EDTA). Supernatant (at 1:2 dilutions),
and cytokine/chemokine standards (serial 1:5 dilutions,
starting from 1 lg/mL) (R&D Systems), were incu-
bated in duplicate, for 2 hours at room temperature,
followed by incubation with alkaline phosphatase (or
peroxidase)-conjugated second antibodies specific for
the respective cytokines/chemokines. The plates were fi-
nally developed with p-nitrophenyl phosphate (pNPP)
or o-phenylenediamine hydrochloride (OPD) substrate
(Sigma Chemical Co.). Optical densities (OD) were read
using a Bio-Kinetics ELISA reader (BioTek Instruments,
Winooski, VT, USA), and the respective concentrations
of cytokines/chemokines were calculated based on the
derived standard curve.
RNA silencing studies
SiRNA (small interfering RNA) was designed
and prepared following established guidelines (http://
www.Ambion.com), at the University of Texas South-
western RNA Core Facility. The sequences of siRNA
used for blocking IRF-1 gene were 5′-GCC GAG ACA
CUA AGA GCA ATT-3′, 5′-UUG CUC UUA GUG
UCU CGG CTT-3′, 5′-UAC CAG AUA GCA CCA CUG
ATT-3′, 5′-UCA GUG GUG CUA UCU GGU ATT-3′,
5′-UGG ACA GGA GUC AUC UUC UTT-3′, and 5′-
AGA AGA UGA CUC CUG UCC ATT-3′. The control
siRNA was a fluorescein isothiocyanate (FITC)-labeled
scrambled oligonucleotide. SiRNA duplexes were made
by annealing single-stranded siRNA. This was then added
dropwise to the mesangial cells in culture, together with
GeneEraser transfection reagent (Stratagene, La Jolla,
CA, USA) at room temperature. After 10 minutes, the
wells were washed, and fresh culture media was added.
After 24 hours of culture, 10 ng/mL LPS was added for
different durations. Transfection efficiency was gauged by
FACS analysis.
Anti-GBM studies
GBM-reactive nephrotoxic serum was prepared as de-
scribed elsewhere [4, 5]. B6 and B6.IRF-1−/− mice were
purchased from Jackson Laboratories, and maintained in
an SPF colony. Two- to three-month-old females were
used for all studies. Nephrotoxic serum nephritis was in-
duced as described previously [4, 5]. Briefly, mice were
sensitized with rabbit IgG on day 0, and administered a
single dose (150 ug per 25 mg body weight) of anti-GBM
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Fig. 1. Mesangial genes turned on 1 hour following lipopolysaccharide (LPS) stimulation. Mesangial cell lines were stimulated with 10 ng/mL LPS.
RNA was extracted 0, 1, 6, 24, and 60 hours poststimulation. Whereas RNA from the unstimulated sample was cyanine-3 (Cy3) labeled, RNA from
the stimulated cells was Cy5-labeled. Both sets of labeled RNA were then cohybridized to 17K oligonucleotide arrays and scanned. After filtering
noise, the intensity in the Cy5 channel was compared to that in the Cy3 channel. Results from three biologic replicates (from three independent
B6-derived mesangial lines, M3, M4, and M14) are presented in successive columns, under each timepoint. The expression patterns of genes that
showed at least a twofold increase following LPS stimulation at the 1-hour time point are depicted. The indicated fold change pertains to the average
fold increase observed in the three mesangial cell lines, at the 1-hour time point. The NCBI/Unigene ID, gene symbol, and gene description are also
indicated.
Fig. 2. Mesangial genes turned on 6 to 24 hours following lipopolysaccharide (LPS) stimulation. Three independent mesangial cell lines were
stimulated with LPS, and studied as detailed in Figure 1. The expression patterns of genes that showed at least a twofold increase following LPS
stimulation only at the 6- and/or 24-hour time points are depicted in this figure. The indicated fold change pertains to the average fold-increase
observed in the three mesangial cell lines, at the 6-hour or 24-hour time point, whichever exhibited a larger fold increase. The NCBI/Unigene ID,
gene symbol, and gene description are also indicated.
“nephrotoxic” sera on day 5. Mice were then monitored
for evidence of disease on day 14. Urinary protein concen-
tration was determined using the Coomassie Plus protein
Assay Kit (Pierce, Rockford, IL, USA). Urine albumin
concentration was assayed using a commercially available
kit (Bethyl Laboratories, Montgomery, TX, USA). Blood
was collected on day 0 and day 14, for measuring blood
urea nitrogen (BUN), using a urea nitrogen kit (Sigma
Chemical Co.).
Statistics
Intergroup comparisons (at the respective time points
at which gene changes were noted) were carried out
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Fig. 3. Mesangial genes turned on 60 hours following lipopolysaccharide (LPS) stimulation. Three independent mesangial cell lines were stimulated
with LPS, and studied as detailed in Figure 1. The expression patterns of genes that showed at least a twofold increase following LPS stimulation
only at the 60-hour time point are depicted in this figure. The indicated fold change pertains to the average fold increase observed in the three
mesangial cell lines, at the 60-hour time point. The NCBI/Unigene ID, gene symbol, and gene description are also indicated.
using analysis of variance (ANOVA), or the Student
t test, unless otherwise indicated. All statistical analyses
were performed using SigmaStat (Jandel Scientific).
RESULTS
Of the large array of genes monitored, a set of five
genes demonstrated rapid and consistent up-regulation
(> twofold) in mesangial cells, within an hour follow-
ing LPS activation. These included IRF-1 (P < 0.02),
ScyA2 (MCP1) (P < 0.007), ScyA20 (MIP3a) (P < 0.04),
ScyB1 (Gro1) (P < 0.006), and ScyB2 (MIP2a/Gro2)
(P < 0.05), as portrayed in Figure 1. Whereas the first is
an interferon regulatory transcription factor, the rest are
all chemokines. Whereas IRF-1 and ScyB2/MIP2a were
down-regulated back to resting levels by 6 hours poststim-
ulation, ScyA2/MCP1, ScyA20/MIP3a, and ScyB1/Gro1
continued to be expressed till at least 6 hours poststim-
ulation; indeed, ScyB1/Gro1 was expressed at least until
60 hours poststimulation, as is evident from Figure 1.
The mesangial transcriptomic profile 6 hours and
24 hours poststimulation with LPS were drastically dif-
ferent from the 1-hour profile, with heightened ex-
pression of a rich array of genes, belonging to many
different functional groups, as illustrated in Figure 2. In
addition to the continued expression of ScyA2/MCP1,
ScyA20/MIP3a( and ScyB1/Gro1 (Fig. 1), two additional
chemokines became hyperexpressed, ScyA7 (MCP3) and
ScyD1 (fractalkine). Important growth factors that were
up-regulated at this time point included GM-CSF (CSF-
2), platelet-derived growth factor (PDGF) and epireg-
ulin [belonging to the endothelial growth factor (EGF)
family]. Several key transcription factors surfaced at
this point, including nuclear factor-jB (NFjB), C/EBPb ,
and C/EBPd. Of these transcription factors, NFjB ap-
peared to be relatively early in its expression profile since
it was modestly up-regulated as early as 1 hour post-
LPS stimulation (albeit at levels that were < twofold),
as is evident from Figure 2. Matrix remodeling en-
zymes, including TIMP-1, were also hyperexpressed at
this time point. Inflammation-related molecules that be-
came up-regulated included PTGS2/COX2, and several
serine/cysteine proteinase inhibitors, including SpI2-1,
Spp1, and plasminogen activated inhibitor-1 (PAI-1). Sur-
face molecules that became up-regulated included vascu-
lar cell adhesion molecule-1 (VCAM-1) and Syndecan-4.
complement factor C3 and defensin beta 1 up-regulation
became prominent at the later, at the 24-hour time
point. A suite of “metabolism”-related genes, includ-
ing Slc21a11, Slc2a1, ALDH1, glutathione, and hexoki-
nase, were also up-regulated at these intermediate (6 to
24 hours) time points. Finally, several novel genes of yet
unknown function were also noted to be up-regulated.
The final microarray time point was at 60 hours
post-LPS stimulation. Most of the genes that were
up-regulated earlier had already been extinguished by
this later time point, with a few exceptions, including
ScyB1/Gro1, C/EBP, oncostatin receptor, C3, CTLA2,
and Saa3, as can be noted from Figure 2. In addition, a
set of new genes was turned on at this late time point, as
diagramed in Figure 3. This included matrix-remodeling
genes, including MMP11, MMP13, and MGLAP. In
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Table 2. Genes that were down-regulated >twpfold, on the average
Gene ID Time of maximal change Average fold change Gene symbol and description
Z37110 1 hour −2.29 Ccng1, cyclin G1
AK018340 1 hour −2.1 RIKEN cDNA 6530415H11 gene
NM 013493 24 hours −3.87 Cnbp, cellular nucleic acid binding protein
NM 008947 24 hours −3.62 Psmc1, protease
NM 013470 24 hours −3.5 Anxa3, annexin A3
NM 025436 24 hours −3.26 Sc4mol, sterol-C4-methyl oxidase-like
NM 019813 24 hours −3.11 Dbn1, drebrin 1
NM 007840 24 hours −2.89 Ddx5, DEAD
NM 008774 24 hours −2.89 Pabpc1, poly A binding protein
NM 009790 24 hours −2.8 Calm1, calmodulin 1
NM 008753 24 hours −2.74 Oaz1, ornithine decarboxylase antizyme
NM 025323 24 hours −2.74 RIKEN cDNA 0610009D07 gene
NM 008972 24 hours −2.69 Ptma, prothymosin alpha
AK013880 24 hours −2.68 Nars, asparaginyl-tRNA synthetase
NM 054044 24 hours −2.66 RIKEN cDNA 9530074E10 gene
BC016232 24 hours −2.55 Cappa1, capping protein alpha 1
AK011566 24 hours −2.52 RIKEN cDNA 2610027H02 gene
NM 009795 24 hours −2.5 Capns1, calpain
AK005460 24 hours −2.49 Cnn3, calponin 3
NM 013556 24 hours −2.46 Hprt, hypoxanthine guanine phosphoribosyl transferase
NM 013715 24 hours −2.45 Cops5, COP9 (constitutive photomorphogenic) homolog
NM 011029 24 hours −2.41 Lamr1, laminin receptor 1
BC005537 24 hours −2.36 Hypothetical protein MGC7474
NM 025360 24 hours −2.21 RIKEN cDNA 1200002G13 gene
NM 009082 24 hours −2.2 Rpl29, ribosomal protein L29
NM 011292 24 hours −2.2 Rbl9, ribosomal protein L9
NM 016786 24 hours −2.18 Hip2, huntington interacting protein 2
NM 013562 24 hours −2.16 Ifrd1, interferon-related developmental regulator 1
NM 019641 24 hours −2.11 Stmn1, stathmin 1
NM 009658 24 hours −2.1 Akrlb3, aldo-keto reductase family 1
NM 018865 24 hours −2.08 Wisp1, WNT1-inducible signaling pathway protein 1
BC010215 24 hours −2.04 Plekha2, pleckstrin homology domain-containing
AB029930 60 hours −4.33 Cav, caveolin
NM 016750 60 hours −3.08 H2A histone family
BC013552 60 hours −2.84 Expressed sequence AU018965
AK013995 60 hours −2.73 RIKEN cDNA 3110004O18 gene
NM 010634 60 hours −2.32 Fabp5, fatty acid binding protein 5
BC010711 60 hours −2.24 Mus, musculus cDNA clone
NM 020332 60 hours −2.19 ank, progressive ankylosis
NM 008342 60 hours −2.17 Igfbp2, insulin-like growth factor binding protein 2
L21027 60 hours −2.14 Phgdh, 3-phosphoglycerate dehydrogenase
NM 013642 60 hours −2.11 Dusp1, protein tyrosine phosphatase
BC021333 60 hours −2.07 RIKEN cDNA 2610034E13 gene
BC008520 60 hours −2 Vcl, vinculin
addition to genes being up-regulated, several genes were
also down-regulated in LPS-triggered mesangial cells.
Summarized in Table 2 are all genes that were down-
regulated twofold or more in at least two of three mesan-
gial cell lines studied. Very few genes showed maximal
down-regulation at the 1-hour and 6-hour time points
(Table 2), as opposed to the 24-hour time point. Finally,
most of the genes down-regulated at the 24-hour time
point also remained suppressed at the 60-hour time point.
To confirm the validity of the above microarray re-
sults, several of the up-regulated genes were selected
for further confirmatory studies, using real-time RT-PCR
assays, or ELISA. Shown in Figure 4 are the message
up-regulation profiles of IRF-1 and ScyB1/Gro1, as as-
certained by real-time PCR. As is clear from Figure 1
and Figure 4, whereas IRF-1 appeared to be a “quick-
on, quick-off” gene, ScyB1/Gro1 was rapidly turned on,
but was persistently expressed. ELISA assays also of-
fered confirmation of increased MCP-1 protein levels
following LPS stimulation (Fig. 4E). Likewise, the data
shown in Figure 5 validate several of the intermediate/late
time point gene changes, including complement C3, GM-
CSF/CSF2, TIMP-1, and MMP-13, using real-time PCR
or ELISA. These confirmatory studies and supporting lit-
erature (see below), together lend credence to the validity
of the transcriptomic findings portrayed in Figures 1 to 3.
From the above results, it was apparent that IRF-1 was
the earliest transcription factor to be hyperexpressed fol-
lowing LPS stimulation, with NFjB being a close sec-
ond. Hence, we wondered if it might be a potential target
for molecular intervention. Before attempting to test the
function of this molecule in mesangial cells, we asked
what other triggers were capable of up-regulating IRF-
1 expression. It became clear that several other innate
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Fig. 4. Confirmation of expression profiles of “early-on” genes. To confirm the microarray results presented in Figure 1, the expression levels
of interferon regulatory factor-1 (IRF-1) and ScyB1/Gro-1 were measured by real-time polymerase chain reaction (PCR). RNA isolated from
unstimulated and lipopolysaccharide (LPS)-stimulated mesangial cells were reverse transcribed (RT), and PCR amplified over a spectrum of
cycles. The cycle number that yielded a threshold level of PCR product was noted (CT), and this was used to calculate the “fold increase” using
the relative CT method, after normalization against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (see Methods section). The IRF-1
(A) and Scy-B1/Gro-1 (B) PCR product levels are plotted as a function of PCR cycle number for three independent mesangial lines that were
either unstimulated or LPS-stimulated for 1 hour. The same data are shown quantitatively in (C) and (D), respectively. Likewise, mesangial cell
monocyte chemoattractant protein-1 (MCP-1) production after LPS stimulation was verified using enzyme-linked immunosorbent assay (ELISA)
(E). Indicated P values pertain to Student t test comparisons of expression levels at “T = 0” versus the expression levels at various time points after
LPS stimulation. Shown results are representative of two to three independent experiments, for each gene studied.
triggers (e.g., poly I:poly C and peptidoglycan), but not
all, also had the potential to up-regulate IRF-1 in mesan-
gial cells (Fig. 6). In addition, INF-c was one of the
most potent triggers of IRF-1 expression. Finally, heat-
aggregated pooled IgG, a surrogate for immune com-
plexes (triggering via FcR), also demonstrated the ca-
pacity to trigger mesangial cell IRF-1 expression. Hence,
IRF-1 appeared to be an early gene turned on in mesan-
gial cells, following several different types of triggers.
Given that IRF-1 was one of the earliest transcription
factors to be turned on following mesangial cell stimula-
tion, we asked what role this molecule might be playing
in the later appearing events. To ascertain this, IRF-1 up-
regulation was first suppressed using an IRF-1 targeted
siRNA construct (or placebo), before LPS stimulation.
As is clear from Figure 7, successful expression of siRNA
(as confirmed by flow cytometry) (Fig. 7A) reduced cel-
lular levels of IRF-1 effectively (Fig. 7B), but was not
capable of dampening other downstream mediators fol-
lowing LPS stimulation (Fig. 7C). Whereas some of the
assayed products have been shown to be transcriptionally
controlled (Figs. 1 to 3), others have previously been doc-
umented to be major products of mesangial cells [1–3].
Somewhat surprised by these negative results, B6.IRF-
1−/− mice were procured, and mesangial cell lines were
isolated for study. As is evident from Figure 8A, mesan-
gial cells from the knockout mice were equally capable of
producing several downstream mediators following LPS
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stimulation. In addition, when subjected to challenge with
rabbit anti-GBM “nephrotoxic” sera, B6.IRF-1−/− mice
suffered a similar extent of proteinuria (including albu-
minuria) and azotemia, as the B6 controls (Fig. 8B).
Finally, the hyperexpressed genes at the different time
points were examined to determine if they shared any
particular transcription factor binding sites. Although the
5 “early on” genes up-regulated 1-hour poststimulation
did not significantly share any particular transcription fac-
tor binding sites, the “intermediate” and “late” appear-
ing genes revealed interesting patterns, with respect to
shared transcription factor binding sites. As portrayed in
Figure 9, a substantial fraction of these genes exhibited
canonical binding sites for C/EBP, NF-ATp, Sp1, and a
couple of other transcription factors. Particularly promi-
nent was the observation that nearly 70% of all interme-
diate and late LPS response genes exhibited Sp1 binding
sites.
DISCUSSION
The above studies point to an ordered expression of
several different classes of molecules in carefully syn-
chronized waves, following LPS stimulation of mesangial
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cells. Although there were no previous reports of mesan-
gial transcriptomes against which the present findings can
be compared, a rich literature exists on the transcrip-
tomes of macrophages, which are related to mesangial
cells in ontogeny. Importantly, with respect to the “early-
on” genes depicted in Figure 1, microarray studies using
mouse and human macrophages have reported the early
up-regulation of ScyB2/MIP2a [7–16], IRF-1 [7–10, 12–
15], ScyA2/MCP-1 [7, 9, 12, 14, 15], and ScyB1/Gro1 [7,
16], following a variety of stimuli, including innate trig-
gers, infection, cytokines, and even physical triggers.
Although we do not have access to a rich literature on
mesangial transcriptomes, several of the above molecules
have been noted to be up-regulated in mesangial cells, fol-
lowing stimulation with LPS or other triggers. Notably, a
large body of literature has detailed the up-regulation
of ScyA2/MCP-1 in stimulated mesangial cells [1–3, 17–
19]; indeed, the critical in vivo role of this molecule
in immune nephritis has also been demonstrated using
ScyA2/MCP-1 knockout mice [20]. In addition, a hand-
ful of reports have described the up-regulation of the
other chemokines in mesangial cells, in resonance with
the findings reported here [1–3, 17–21]. Collectively, the
above studies in macrophages and mesangial cells further
validate the observed changes in the present microarray
study.
With respect to the transcription factors that were hy-
perexpressed, IRF-1 and NFjB were the earliest to be up-
regulated, though only the former was expressed in excess
of twofold at the 1-hour time point. The role of NFjB in
mesangial cell stimulation has previously been demon-
strated [22–24]. The present communication evaluates
the potential importance of the other early transcription
factor, IRF-1. Although the literature on mesangial IRF-
1 is rather limited, this is a well-studied molecule in other
cell models. Indeed, both IRF-1 and NFjB exhibit tran-
scriptional synergy as they come together to generate
“enhancesomes,” which also include other factors such
as activating transcription factor (ATF)-2/c-Jun and 3-
hydroxy-3-methylglutaryl (HMG)-I [25, 26]. Importantly,
IRF-1 has been documented in the transcriptional con-
trol of many genes, including type I IFN [27], MMPs [28],
VCAM-1 [29], and COX-2 [30], several of which have
been noted to be up-regulated in the present study (Figs. 2
and 3).
This is also the first documentation of IRF-1 up-
regulation in mesangial cells following a wide spectrum of
triggers, innate or otherwise. It is known that mesangial
cells can be triggered via FcR [31, 32], and the present
communication highlights IRF-1 expression as an early
consequence of this signaling (Fig. 7). Given that IRF-
1 is an early transcriptional regulator in mesangial cells
following a wide spectrum of triggers, it seemed to be an
attractive target for modulation. Surprisingly, the delib-
erately blocking IRF-1, as well as the genetic deficiency
of IRF-1, both failed to subdue the expression of key
downstream molecules (Figs. 7 and 8). It is possible that
IRF-1 may be redundant, or unnecessary for the biologic
responses being examined in this communication, with
respect to the role of particular in vitro and in vivo stim-
uli used. In this respect, for example, the biological rele-
vance of IRF-1 has largely been demonstrated in response
to INF stimulation [28 30, 33].
Moreover, the optimal firing of downstream path-
ways in mesangial cells may be contingent upon syn-
ergy between several different transcriptional factors,
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including NFjB and IRF-1, C/EBP, etc. [25, 26, 33], all
of which were up-regulated in LPS-triggered mesangial
cells (Fig. 2). In addition, the mesangial cell response fol-
lowing LPS stimulation may also be programmed by yet
other transcription factors such as Sp1, and NFAT-p, as
revealed by the computer-based search against the pub-
licly accessible transcription factor database (Fig. 9). In-
deed, the roles of several of these transcription factors in
endotoxin-triggered biologic responses have been richly
documented in other cell systems [34–40]. It remains to
be shown if any of these factors play an obligatory role in
mesangial cell response to LPS stimulation.
LPS has been widely used as an in vitro trigger for a
large number of cell types, including mesangial cells. In-
deed, when coadministered with organ-specific autoanti-
bodies (e.g., anticollagen or antiglomerular antibodies),
it has been observed to precipitate profound end organ
disease. Hence, it has turned out to be an excellent ex-
perimental tool for studying cellular function in vitro and
end-organ disease in vivo. On the other hand, one may
ask if the use of LPS as a trigger has any biologic rel-
evance. Given that LPS stimulates cellular processes via
Toll receptors, and the recent observation that an increas-
ing number of self-molecules (e.g., heat shock proteins,
fibronectin) can also trigger the same toll receptors [41–
42], it is attractive to posit that some of these endogenous
ligands may have the potential to impact the very same
biologic pathways influenced by LPS. Identifying the
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endogenous ligands within the glomerular milieu that
may potentially engage toll receptors on mesangial cells
is a challenge that lies ahead.
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